Wanbury Limited Receives Secretarial Compliance Report for FY26 with Minor Violation

2 min read     Updated on 25 Apr 2026, 04:36 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Wanbury Limited's FY26 secretarial compliance report shows one violation - delayed shareholding pattern submission resulting in ₹42,480 BSE fine, which has been paid. The company successfully resolved previous year's board composition issues by appointing new independent directors and reconstituting committees. Overall compliance across SEBI regulations remains satisfactory with significant improvement from previous year.

powered bylight_fuzz_icon
38617578

*this image is generated using AI for illustrative purposes only.

Wanbury Limited has received its secretarial compliance report for the financial year ended March 31, 2026, prepared by practicing company secretary Kala Agarwal. The comprehensive report examines the company's adherence to various SEBI regulations and securities laws during the review period.

Current Year Compliance Status

The report identifies one compliance violation during FY26. The company delayed submission of its shareholding pattern for the quarter ended September 30, 2025, which resulted in regulatory action by BSE Limited.

Violation Details: Information
Compliance Requirement: Submission of Shareholding Pattern within Prescribed timeline
Regulation: Regulation 31 of SEBI (LODR) Regulations, 2015
Violation: Delay in submission for quarter ended September 30, 2025
Penalty Amount: ₹42,480 (including GST)
Fine Payment Date: November 27, 2025 via NEFT
Current Status: Regularized, no further action pending

Resolution of Previous Year Issues

The report demonstrates significant progress in addressing compliance issues identified in the previous year's secretarial audit. Wanbury has successfully resolved multiple board composition and committee structure violations that had resulted in substantial penalties.

Board Composition Improvements

The company has strengthened its board structure by appointing new independent directors:

  • Mr. Manoj Khubchand Gursahani - appointed as Non-Executive Independent Director on January 8, 2025
  • Pallavur Sankar Dass Vaidyanathan - appointed as Non-Executive Independent Director on January 8, 2025
  • Mr. Mridul S. Mehta - previously appointed as Non-Executive Independent Director on August 12, 2024

Committee Reconstitution

The appointments have enabled proper reconstitution of board committees that had fallen below required strength:

Committee Previous Issue Resolution
Audit Committee Only 2 directors (minimum 3 required) Properly constituted with adequate members
Nomination & Remuneration Committee Only 2 directors Reconstituted on January 8, 2025
Board Composition Below 6 directors Restored to required strength

Comprehensive Compliance Assessment

The secretarial audit examined compliance across multiple regulatory frameworks including SEBI LODR Regulations 2015, SEBI Prohibition of Insider Trading Regulations 2015, and various other securities regulations. The company demonstrated satisfactory compliance in key areas:

  • Secretarial Standards: Full compliance with applicable standards issued by ICSI
  • Policy Adoption: All required policies adopted and updated timely
  • Website Maintenance: Functional website with proper document dissemination
  • Director Disqualification: No directors disqualified under Companies Act 2013
  • Related Party Transactions: Prior audit committee approval obtained
  • Insider Trading: Compliance with prohibition regulations maintained

Regulatory Framework Coverage

The audit covered compliance with extensive regulatory requirements including Securities and Exchange Board of India Act 1992, Securities Contracts Regulation Act 1956, and specific SEBI regulations covering listing obligations, capital issues, takeovers, buyback of securities, employee benefits, and depositories.

The report confirms that Wanbury Limited has substantially improved its regulatory compliance framework, with only one minor violation during FY26 compared to multiple significant issues in the previous year. The company's proactive approach to addressing board composition requirements and timely payment of penalties demonstrates commitment to maintaining robust corporate governance standards.

Historical Stock Returns for Wanbury

1 Day5 Days1 Month6 Months1 Year5 Years
-1.34%-2.83%+9.35%+11.11%-9.01%+172.24%

Will Wanbury's improved board composition and governance framework help attract institutional investors in the coming quarters?

How might the company's compliance track record impact its ability to raise capital or pursue strategic partnerships in FY27?

What additional governance measures is Wanbury likely to implement to prevent future regulatory violations?

Wanbury Limited Confirms Non-Large Corporate Status Under SEBI Debt Securities Regulations

1 min read     Updated on 08 Apr 2026, 11:41 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Wanbury Limited has notified BSE and NSE that it does not qualify as a Large Corporate under SEBI debt securities circular dated April 8, 2026. The notification references SEBI circulars from October 19, 2023, and November 26, 2018, regarding fund raising by debt securities issuance. Company Secretary Jitendra J. Gandhi signed the formal communication confirming the company's non-compliance with Large Corporate criteria under the regulatory framework.

powered bylight_fuzz_icon
37217517

*this image is generated using AI for illustrative purposes only.

Wanbury Limited has officially communicated to stock exchanges that it does not qualify as a Large Corporate under the Securities and Exchange Board of India (SEBI) debt securities regulations. The pharmaceutical company made this disclosure through a formal notification dated April 8, 2026.

Regulatory Compliance Notification

The company's notification specifically addresses the SEBI circular SEBI/HO/DDHS/DDHS-RACPOD1/P/CIR/2023/172 dated October 19, 2023, and SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. These circulars pertain to fund raising by issuance of debt securities by large entities.

Parameter: Details
Notification Date: April 8, 2026
SEBI Circular Reference: SEBI/HO/DDHS/DDHS-RACPOD1/P/CIR/2023/172 (Oct 19, 2023)
Additional Reference: SEBI/HO/DDHS/CIR/P/2018/144 (Nov 26, 2018)
Corporate Status: Does not qualify as Large Corporate

Official Communication

Company Secretary Jitendra J. Gandhi signed the notification sent to both BSE Limited and National Stock Exchange of India Limited. The communication confirms that Wanbury Limited does not fall within the criteria mentioned under the SEBI circular and therefore does not qualify as a Large Corporate.

Exchange Notification Details

The formal notification was addressed to the listing departments of both major Indian stock exchanges. BSE Limited received the communication referencing scrip code 524212, while NSE received it with symbol WANBURY. The company requested both exchanges to acknowledge receipt and maintain the information in their records.

Corporate Information

Wanbury Limited operates from its registered office at BSEL Tech Park, B-wing, 10th Floor, Sector-30 A, opposite Vashi Railway Station, Vashi Navi Mumbai. The company maintains its corporate identification number as L51900MH1988PLC048455, indicating its incorporation in Maharashtra in 1988.

Historical Stock Returns for Wanbury

1 Day5 Days1 Month6 Months1 Year5 Years
-1.34%-2.83%+9.35%+11.11%-9.01%+172.24%

What are the specific financial thresholds that determine Large Corporate status under SEBI regulations, and how close is Wanbury to meeting them?

Will Wanbury's non-Large Corporate status limit its future debt fundraising options or affect its cost of capital?

Could this classification impact Wanbury's ability to compete with larger pharmaceutical companies for major contracts or partnerships?

More News on Wanbury

1 Year Returns:-9.01%